关于公开征求《硼中子俘获治疗药物临床研发技术指导原则（征求意见稿）》意见的通知-2026/4/28

Document: Data protection notice for legal entity and bank account validation regarding payments-2026/6/8

国家药监局药审中心关于发布《化学仿制药口服调释制剂乙醇剂量倾泻试验药学研究技术指导原则》的通告（2022年第38号）-2022/11/8

Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act Guidance for Industry(Final)-2023/03/16

国家药监局综合司关于同意吉林省药品检验研究院增加生物制品批签发证明文件授权签发人的复函-2023/9/27

Document: Annex to interim measures regarding notification of pharmacovigilance alerts by marketing authorisation holders under Regulation (EU) 2019/6: contact points-2025/1/6

Document: Consolidated 3-year work plan for the Emergency Task Force (ETF)-2025/2/11

国家药监局综合司关于印发2025年医疗器械行业标准制修订计划项目的通知-2025/3/19

Document: Business process description for pharmacovigilance-2025/4/22

Document: Product Management Service (PMS) – Frequently Asked Questions (FAQs)-2025/6/3